Symetryx Corp - Insider Non-Derivative Transactions at NeuBase Therapeutics, Inc. (NBSE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 18, 2023, Symetryx Corp's relationship to NeuBase Therapeutics, Inc. (NBSE) is TenPercentOwner, and currently has 0 shares of Common Stock, Par Value $0.0001 per Share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NBSE insiders.
Data Source: SEC.
Symetryx Corp - Insider Non-Derivative Transactions of NBSE Common Stock, Par Value $0.0001 per Share
Symetryx Corp - Insider Non-Derivative Transactions at NBSE
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Sep 19, 2023 | Sell -- (Common Stock, Par Value $0.0001 per Share) | 50000 | 1.19 | 0 |
Sep 16, 2023 | Sell -- (Common Stock, Par Value $0.0001 per Share) | 103337 | 1.26 | 50000 |
Sep 15, 2023 | Sell -- (Common Stock, Par Value $0.0001 per Share) | 129108 | 1.44 | 153337 |
Sep 12, 2023 | Sell -- (Common Stock, Par Value $0.0001 per Share) | 3376 | 1.44 | 472926 |
Sep 9, 2023 | Sell -- (Common Stock, Par Value $0.0001 per Share) | 128847 | 1.53 | 476302 |
Sep 8, 2023 | Sell -- (Common Stock, Par Value $0.0001 per Share) | 74852 | 1.8 | 605149 |
Sep 2, 2023 | P -- (Common Stock, Par Value $0.0001 per Share) | 61076 | 0.98 | 680081 |